Collegium Pharmaceutical, Inc. Common Stock
|Range Today||$11.67 - $11.92|
|52 Week Range||$7.37 - $18.67|
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of next-generation abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. Its products includes Xtampza ER, and ONSOLIS. Xtampza ER provides adequate pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The ONSOLIS is a transmucosal immediate release fetanyl film indicated for the management of breakthrough pain in cancer patients. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Canton, MA.